Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines

Abstract

To investigate the expression of Bcl-2 and Bcl-xl gene in sensitive (A2780) and drug-resistance (AD6) human ovarian cancer cell lines and explore the molecular mechanism of multidrug resistance. A2780 and AD6 were detected by using DNA gel electrophoresis, flow cytometry and RT-PCR. Our results showed that (1) “DNA ladder” was observed in A2780 and AD6 after cisplatin treatment; (2) after 3.0, 6.0, 9.9 μg/ml of cisplatin treatment, a significant difference was noted in the rate of apoptosis between in A2780 and AD6 (P<0.05); (3) Bcl-2 and Bcl-xl genes were overexpressed in AD6. After cisplatin treatment, the expression of Bcl-2 and Bcl-xl genes was down-regulated in A2780 and AD6. It is concluded that cisplatin could induce the apoptosis of ovarian cancer cells, and the over-expression of Bcl-2 and Bcl-xl genes may contribute to apoptotic inhibition and the development of multidrug-resistance of human ovarian cancer.

Keywords

ovarian cancer / apoptosis / multidrug-resistance / Bcl-2 and Bcl-xl / cisplatin

References

[1] MeynR E, StephensL C, HunterM R, et al. . Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer, 1995, 60725-725

[2] MesnerP W, BudihardjoI I, KaufmannS H. Chemotherapy-induced apoptosis. Adv Pharmacol, 1997, 41461-461

[3] GuangS Z, TuC Q, ZhangG Y, et al. . Indomethacin induces apoptosis and inhibits proliferation in chronic myloid leukmia cells. Leukemia Research, 2000, 24(5): 385-385

[4] AlessandroQ, LauraP, ValeriaS, et al. . Quantilation of bcl-2 oncogene in cultured lymphomal/leukemia cell lines and in primary leukemia B-cells by a highly sensitive RT-PCR method. Heamatologica, 1995, 80(6): 495-495

[5] RajnceA, MihirT, WendiL, et al. . Fas-activated apoptosis and apoptosis mediators in human trabecular meshwork cells. Exp Eye Res, 1999, 68583-583

[6] CureH, BayJ O, PlagneR, et al. . High-dose chemotherapy in advanced epithelial ovarian cancer. Bull canner, 2001, 88(9): 842-842

[7] MiyashitaT, ReedJ C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 1993, 81(1): 151-151

[8] KuhlJ S, KrajewskiS, DuranG E, et al. . Spontaneous overexpression of the long form of the bcl-x protein in a highly resistant p388 leukemia. Br J Cancer, 1997, 75268-268

[9] OltvaiZ N, MillimanC L, KorsmeyerS J. Bcl-2 heterodimerizesin vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 1993, 74(4): 609-609